Anzeige
Mehr »
Login
Freitag, 03.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
"Special Situation"-Aktie mit Multi-Tenbagger-Potenzial im heißesten Rohstoff-Markt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
52 Leser
Artikel bewerten:
(0)

Symbiosis Healthcare Plc - Further delays in Filing of Audited Accounts

Symbiosis Healthcare Plc: Further delays in filing Audited Accounts

Dated: 07 January 2015


"SYMB" or "The Company"

The Board wishes to inform the members that there is a further delay in the
filing of the Company's Audited Financial Statements.

The cause of the delay was that in December the previous auditor was advised of
a change in their status and permissions by their professional regulators,
which meant that they are no longer allowed to audit, listed companies. As a
consequence they resigned from the engagement.

The company was then presented with the task of identifying and appointing a
new auditor so late in the year. The intervening Christmas and New Year
holidays acerbated the situation.

The Board also wishes to inform the members that a new auditor for the company
has been identified and that clearance has been received for them to be engaged
this week. As soon as the auditors have been appointed in the next day or two,
a formal announcement to the members via the company website shall be made with
an indication of the expected date of completion of the audit.

The Board takes this opportunity to assure the members that the planned Board
changes shall go ahead as announced late last year. The invigorated Board is
committed to securing a listing for the company in an alternative more liquid
market that will enhance their ability to trade their shares, something that
unfortunately was not achieved with GXG.

Please refer to the company's website (symbiosis-healthcare.com) from now on
for news of further developments.

Should you require further clarification, please contact William Albert
Securities Limited (info@williamalbert.com)

THE DIRECTORS OF THE COMPANY ACCEPT RESPONSIBILITY FOR THE CONTENTS OF THIS
ANNOUCEMENT.

For further information please contact:
Symbiosis Healthcare Plc
Mr. Bhinder Singh Purewal
Dr M A Mirza, Director,
and Em: aleem.mirza@symbiosis-healthcare.com
Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2015 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.